Bayer HealthCare Introduces Seresto™, Offering Easy-To-Use Flea and Tick
Control for Dogs or Cats that Lasts Eight Months
Reduces the hassle of remembering to apply monthly treatments
SHAWNEE, Kan., May 2, 2013
SHAWNEE, Kan., May 2, 2013 /PRNewswire/ --Bayer HealthCare LLC Animal Health
Division has now provided dog and cat owners the same performance they expect
from a monthly flea and tick topical in an easy-to-use, convenient collar that
protects for eight months. Seresto™, manufactured by Bayer, is an effective
flea and tick preventive providing pet owners with a long-lasting treatment
alternative that reduces the hassle of remembering to apply monthly
To view the multimedia assets associated with this release, please click:
Seresto features a sustained release technology that gives cats or dogs eight
months of uninterrupted protection against fleas and ticks, making it
different from other collars and monthly topicals. Flumethrin and
imidacloprid, the collar's active ingredients, are continuously replenished
over the animal's skin and hair in low concentrations for eight months. As a
result, Seresto kills fleas within 24 hours and ticks within 48 hours after
initial application. Reinfesting fleas are killed within two hours and
reinfesting ticks are killed in as quickly as six hours.
"No other flea or tick preventive provides eight months of effective flea and
tick protection with only one application for both dogs or cats," said Ian
Spinks, President and General Manager, Bayer HealthCare LLC Animal Health
Division, North America. "Bayer HealthCare Animal Health wants to be the go-to
company for parasiticide solutions. With Seresto, we give pet owners a new
alternative to spot-on topical flea and tick, and oral flea prevention."
The Companion Animal Parasite Council recommends year-round protection against
fleas and ticks. But the truth is, many pet owners live busy lives and tend to
forget monthly treatments or only apply treatments during months when fleas
and ticks are most prevalent. This can put their pets at a greater risk for an
infestation by fleas or ticks. Infected ticks can transmit organisms that can
cause diseases, including Lyme disease and Rocky Mountain spotted fever, and
flea infestations can cause serious discomfort for pets. Seresto kills fleas
and repels and kills ticks. If a tick is repelled or killed it cannot attach
to a dog or cat and transmit organisms that may cause disease.
The design of Seresto includes a ratchet-release system and, on the small dog
and cat collars, a pre-determined breaking point. This is important, so that
in the unlikely event of a cat or a dog being trapped, the pet's own strength
is sufficient to allow for a quick release.
Seresto is available in veterinary clinics, pet specialty stores and
participating online pet retailers. All of Bayer's products are competitively
priced. Product pricing varies across the U.S. Pet owners should visit their
local veterinary clinic or pet specialty store to determine pricing in their
immediate area. Each collar comes with three optional reflectors for added
visibility at night. Seresto is available for cats, for small dogs up to 18
pounds, and for large dogs above 18 pounds.
About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of
health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup
of Bayer AG with annual sales of EUR 39.8 billion (2012), is one of the
world's leading, innovative companies in the healthcare and medical products
industry and is based in Leverkusen, Germany. The company combines the global
activities of the Animal Health, Consumer Care, Medical Care and
Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop,
manufacture and market products that will improve human and animal health
worldwide. Bayer HealthCare has a global workforce of 55,300 employees
(Dec.31, 2012) and is represented in more than 100 countries. Find more
information at www.bayerhealthcare.com.
Find more information at www.animalhealth.bayerhealthcare.com.
This release may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management. Various
known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. These
factors include those discussed in Bayer's public reports which are available
on the Bayer website at www.bayer.com. The company assumes no liability
whatsoever to update these forward-looking statements or to conform them to
future events or developments.
SOURCE Bayer HealthCare LLC
Contact: Staci Gouveia, Tel. 913.268.2577, firstname.lastname@example.org; or Lauren
Dorsch, Tel. 913.268.2747, email@example.com
Press spacebar to pause and continue. Press esc to stop.